Last $2.70 USD
Change Today +0.05 / 1.89%
Volume 94.8K
BTX On Other Exchanges
Symbol
Exchange
BTX is not on other exchanges.
As of 8:04 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Arnold I. Burns

Former Director, Chairman of Audit Committee, Chairman of Compensation Committee and Member of Nominating/Corporate Governance Committee, BioTime, Inc.
AgeTotal Calculated CompensationThis person is connected to 98 board members in 4 different organizations across 8 different industries.

See Board Relationships
84$10,625

Background*

Mr. Arnold I. Burns, Arnie served as Managing Director of Corporate Finance at Arnhold and S. Bleichroeder, Inc. from February 1999 to December 2002. From December 2002 to January 2004, Mr. Burns served as Managing Director, Corporate Finance and Senior Partner at Natixis Bleichroeder Inc. (also known as Natexis Bleichroeder Inc.). He was practicing attorney for nearly 40 years including Senior Partner of Proskauer Rose LLP from September 1988 to January 1999. He served ...

Read Full Background

Corporate Headquarters*

1301 Harbor Bay Parkway
Alameda, California 94502

United States

Phone: 510-521-3390
Fax: 510-521-3389

Board Members Memberships*

Former Director
Director
Former Member of Board of Governors
Director
Director, Member of Audit Committee and Member of Governance & Nominating Committee
1994-Present
Director, Member of Audit Committee, Member of Compensation Committee, Member of Executive Committee and Member of Ad Hoc Committee
2006-2007
Former Director
2007-2008
Former Independent Director
2009-2013
Former Director, Chairman of Audit Committee, Chairman of Compensation Committee and Member of Nominating/Corporate Governance Committee

Education*

JD
Cornell University School of Law

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$10,625
Total Calculated Compensation$10,625
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
BTX:US $2.70 USD +0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$568.8K
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$406.6K
Martin M. McGlynn Chief Executive Officer, President, Director, Member of Strategic Transactions Committee, Chief Executive Officer of StemCells California Inc and President of StemCells California Inc
StemCells Inc.
$835.8K
Robin L. Smith M.D., MBA,RoExecutive Chairman and Chief Executive Officer
Neostem, Inc.
$945.0K
Paul K. Wotton Ph.D.Chief Executive Officer and President
Advanced Cell Technology Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BIOTIME INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.